Basic Information | Post buying leads | Suppliers |
Name |
7-Benzoyloxymethyl-12-methylbenz(a)anthracene |
EINECS | N/A |
CAS No. | 31012-29-0 | Density | 1.227g/cm3 |
PSA | 26.30000 | LogP | 6.81160 |
Solubility | N/A | Melting Point |
N/A |
Formula | C27H20 O2 | Boiling Point | 595.1°Cat760mmHg |
Molecular Weight | 376.455 | Flash Point | 251.7°C |
Transport Information | N/A | Appearance | N/A |
Safety | Questionable carcinogen with experimental neoplastigenic data. See also ESTERS. When heated to decomposition it emits very acrid smoke and irritating fumes. | Risk Codes | N/A |
Molecular Structure | Hazard Symbols | N/A | |
Synonyms |
Benz[a]anthracene-7-methanol,12-methyl-, benzoate (8CI,9CI); 7-Benzoyloxymethyl-12-methylbenz(a)anthracene; 7-Benzoyloxymethyl-12-methylbenz[a]anthracene |
Molecular Structure of 7-Benzoyloxymethyl-12-methylbenz(a)anthracene (CAS NO.31012-29-0):
IUPAC: (12-Methyltetraphen-7-yl)methyl benzoate
Molecular Formula: C27H20O2
Molecular Weight: 376.4465
H bond acceptors: 2
Density: 1.227 g/cm3
Flash Point: 251.7oC
Boiling Point: 595.1oC at 760 mmHg
Index of Refraction: 1.718
Surface Tension: 54.5 dyne/cm
Molar Volume: 306.6 cm3
Enthalpy of Vaporization: 88.69 kJ/mol
Vapour Pressure: 3.96E-14 mmHg at 25oC
Product Categories: Tumor data
SMILES: O=C(OCc3c4c(c(c2c1ccccc1ccc23)C)cccc4)c5ccccc5
InChI: InChI=1/C27H20O2/c1-18-21-12-7-8-14-23(21)25(17-29-27(28)20-10-3-2-4-11-20)24-16-15-19-9-5-6-13-22(19)26(18)24/h2-16H,17H2,1H3
InChIKey: MXZZITVTYIZHJN-UHFFFAOYAH
Questionable carcinogen with experimental neoplastigenic data. See also ESTERS. When heated to decomposition it emits very acrid smoke and irritating fumes.
7-Benzoyloxymethyl-12-methylbenz(a)anthracene with cas registry number of 31012-29-0 is also known as 12-Methylbenz(a)anthracene-7-methanol benzoate (ester) ; Benz(a)anthracene-7-methanol, 12-methyl-, benzoate . It would emit very acrid smoke and irritating fumes when heated to decomposition. 7-Benzoyloxymethyl-12-methylbenz(a)anthracene with cas registry number of 31012-29-0 is used as a pharmaceutical intermediate .